Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 40,000 | 330.40 k | 40,000 |
19 Aug 24 | EYPT EyePoint Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 7.98 | 12,500 | 99.75 k | 16,500 |
11 Jul 24 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,000 | 0.00 | 4,000 |
11 Jul 24 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,000 | 0.00 | 2,000 |
21 Mar 24 | AXGN AxoGen | Common Stock | Sell | Dispose S | No | No | 7.68 | 3,166 | 24.31 k | 1,143,788 |
21 Mar 24 | AXGN AxoGen | Common Stock | Sell | Dispose S | No | No | 7.68 | 3,086 | 23.70 k | 1,133,979 |
21 Mar 24 | AXGN AxoGen | Common Stock | Sell | Dispose S | No | No | 7.68 | 33,028 | 253.66 k | 1,124,565 |
16 Mar 24 | AXGN AxoGen | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,975 | 0.00 | 1,146,954 |
16 Mar 24 | AXGN AxoGen | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,500 | 0.00 | 1,137,065 |
16 Mar 24 | AXGN AxoGen | Common Stock | Option exercise | Acquire M | No | No | 0 | 84,847 | 0.00 | 1,157,593 |